基酶XcP4H的定向进化,用于增强5HTP的产生,用于治疗抑郁症的工程益生菌
Xiaowei Gao1, Yingjie Sun2, Yanhong Yang2
1Green Pharmaceutical Technology Key Laboratory of Luzhou, School of Pharmacy, Southwest Medical University, Luzhou 646000, China; State Key Laboratory of Neurology and Oncology Drug Development, Nanjing 210000, China.
International journal of biological macromolecules
|March 20, 2025
概括
工程细菌产生5-基酸 (5-HTP) 作为抑郁症的活疗法. 这种益生菌方法改善了肠道和大脑的健康,提供了一个新的治疗策略.
科学领域:
- 生物技术是生物技术.
- 微生物学 微生物学
- 神经科学是一个神经科学.
背景情况:
- 抑郁症有复杂的原因,目前的治疗方法也有局限性.
- 5-基三 (5-HTP) 对抑郁症有很大的前景,但其药理动力学不佳.
- 大肠杆菌尼斯尔1917 (EcN) 是为体内5-HTP生物合成而设计的.
研究的目的:
- 为5-HTP生产设计一种高产量的EcN菌株.
- 为了开发一种活生生的益生菌治疗抑郁症.
- 在小鼠模型中研究工程EcN的治疗效果.
主要方法:
- 使用遗传密码扩展的氧酶XcP4H的酶导向进化.
- 在 EcN 中的路径工程和基因编辑.
- 在小鼠中使用工程 EcN (EcN@5-HTP) 作为活体治疗剂.
主要成果:
- 经过工程设计的XcP4H显示,5-HTP的产量增加了22倍.
- 在小鼠中,EcN@5-HTP减轻了类似抑郁的行为.
- 治疗增加了5-HT水平,修复了神经问题,减少了炎症,并调节了肠道微生物群.
结论:
- 合成生物学和酶进化成功地解决了5-HTP的药物动力学限制.
- 工程 EcN 充当活疗法,影响肠道和大脑健康.
- 这种益生菌方法表明,它有可能彻底改变抑郁症治疗的方法.
更多相关视频
12:21Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
15.0K
07:59A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
9.7K
相关概念视频
Evolution of New Traits in Microbes
167
Microorganisms evolve rapidly due to their large population sizes and short generation times, often exhibiting measurable changes within days under laboratory conditions. Natural selection acts on standing genetic variation, enabling the retention and amplification of beneficial traits that confer fitness advantages in changing environments.Adaptive Pigment Regulation in RhodobacterIn Rhodobacter, a genus of purple non-sulfur bacteria, light-harvesting pigments such as bacteriochlorophyll and...
167
Bioreactor Controls-III
55
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
55
Production of Pharmaceuticals
70
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
70
